Concord Biotech IPO Date, Review, Price, Allotment Details

Concord Biotech Limited is an R&D-driven biopharma Company based in Ahmedabad. They are one of the leading global developers and manufacturers of Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations. Concord Biotech has a global presence in more than 70 countries worldwide with efficient distribution infrastructure in markets like the USA, Europe, Japan, Latin America, Africa, and Asia, besides a significant presence in the Indian market. Concord is actively expanding its horizons by partnering with leading global pharmaceutical companies by meeting their product development needs for APIs & finished formulations.

They have six fermentation-based immunosuppressant APIs, including tacrolimus, mycophenolate mofetil, mycophenolate sodium, cyclosporine, sirolimus, and pimecrolimus. Their aim is to continue to grow their immunosuppressant API portfolio, which will remain one of the key contributors to the API business in the near future. In addition to our immunosuppressant API portfolio, they aim to increase APIs sales across other therapeutic areas, especially the (i) Anti-infective APIs. Our anti-infective APIs (ii) Oncology drug APIs. They offer six oncology drug APIs, including temsirolimus, everolimus, romidepsin, mitomycin, dactinomycin, and midostaurin.

As of March 31, 2022, they had 22 API products. They have three manufacturing facilities in the state of Gujarat, India. They have established two DSIR-approved R&D units with 163 members as of March 31, 2022. They have over 200 customers in over 70 countries as of March 31, 2022, for their APIs and formulations. They also entered into long-term supply agreements with some of our customers. Their API customers include Intas Pharmaceuticals Limited and Glenmark Pharmaceuticals Limited.

Objects of the Issue

• Achieve the benefits of listing Equity Shares on the Stock Exchanges
• Carry out the Offer for Sale of up to 20,925,652 Equity Shares by the Selling Shareholder.

Concord Biotech IPO Review (Apply or Not)

• May Apply

Brokerage Firm IPO Review

• Capital Market: To be updated soon
• Religare Broking: To be updated soon
• Hem Securities: To be updated soon
• Arihant Capital: To be updated soon

Concord Biotech IPO Date & Price Band Details

Concord Biotech IPO Market Lot

The Concord Biotech IPO minimum market lot is 20 shares with ₹14,820 application amount. The retail investors can apply up-to 13 lots with 260 shares or ₹192,660 amount.

Concord Biotech IPO Allotment & Listing Dates

The Concord Biotech IPO date is August 4 and the close date is August 8. The Concord Biotech IPO allotment will be finalized on August 11 and the IPO listing on August 18.

You can check IPO subscription status and IPO allotment status on their respective pages.

Concord Biotech IPO Form

How to apply for the Concord Biotech IPO? You can apply for Concord Biotech IPO via ASBA available in your bank account. Just go to the online bank login and apply via your bank account by selecting the Concord Biotech IPO in the Invest section. The other option is you can apply for Concord Biotech IPO via IPO forms downloaded via NSE and BSE. Check out the Concord Biotech forms – Click BSE Forms & NSE Forms blank IPO forms download, fill, and submit in your bank or with your broker.

Concord Biotech Company Financial Report

Concord Biotech IPO Valuation – FY2023

Check Concord Biotech IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.

Peer Group

• Divi’s Laboratories Limited
• Suven Pharmaceuticals Limited
• Laurus Labs Limited
• Shilpa Medicare Limited

Company Promoters

• SUDHIR VAID
• ANKUR VAID

Concord Biotech IPO Registrar

Link Intime India Private Limited
Tel: +91 22 4918 6200
E-mail: [email protected]
Website: www.linkintime.co.in

Concord Biotech IPO Allotment Status Check

Check Concord Biotech IPO allotment status on Linkintime website allotment URL. Click Here

Concord Biotech IPO Lead Managers aka Merchant Bankers

• Kotak Mahindra Capital Company Limited
• Citigroup Global Markets India Private Limited
• Jefferies India Private Limited

Company Address

Concord Biotech Limited
1482-86, Trasad Road, Dholka,
Ahmedabad – 382225, Gujarat, India
E-mail: [email protected]
Website: www.concordbiotech.com

Concord Biotech IPO FAQs

Read Also:

• Lamosaic India IPO Subscription Status – IPO Open
• NTPC Green Energy IPO Subscription Status – IPO Open
• Abha Power IPO GMP, Grey Market Premium Today
• Abha Power IPO Date, Review, Price, Allotment Details
• Edelweiss Financial Services NCD October 2024 – Effective Yield 10.99% p.a.